Transaction · 0001171843-26-006977

Nijhawan Pardeep

Nijhawan Pardeep, CEO, reported a transaction classified as grant at Edesa Biotech, Inc. involving 27602.000000 shares for an estimated $0.00. Reported holdings after the transaction were 933595.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
EDSAEdesa Biotech, Inc.
Trade date
Oct 28, 2026
Filing date
Oct 29, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded27.6k$0.00 per share
Holdings after933kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

EDSA price since this filing

Daily closing prices, with the filing date and available return windows
EDSA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +35.2%1w ago +5.6%1d ago -2.6%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001171843-26-006977
Common Shares
Transaction date
Oct 28, 2026
Filed Oct 29, 2026, 09:02 PM · 1d delay
Shares
27,602 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
933,595 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These restricted stock awards ("RSUs") represent awards r…

  2. F2F3(2 footnotes)

    Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of th…

Original filing · 0001171843-26-006977
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

EDSA